Skip to content

Efficacy of Apium graveolense and Trachyspermum copticum on postprandial syndrome

Efficacy of Apium graveolense and Trachyspermum copticum versus Domperidone on clinical symptoms of patients with postprandial distress syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150927024228N2
Enrollment
100
Registered
2019-03-08
Start date
2019-02-20
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group: Apium Graveolense beans 110 mg plus Trachyspermum Copticum beans 110 mg, three times daily,after meal, for 4 weeks. Intervention 2: Control group: Domperidone table

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 18 to 60 year-old patients with functional dyspepsia Presence of symptoms of postprandial distress syndrome

Exclusion criteria

Exclusion criteria: Pregnancy and Lactation History of convulsion Use of chemical and herbal drugs of dyspepsia Serious diseases like diabetes and cardiovascular diseases History of gastrointestinal surgery Severe mental retardation Drug abuse Use of anticoagulant drug History of side effects related to use of herbal or chemical medicines History of peptic ulcer or gastrointestinal reflux disease Presence of any structural disorder in endoscopy during the last three months Presence of irritable bowel syndrome The patient's unwillingness to continue the study, or unwillingness to signing the concent form Presence of any alarming sign (severe weight loss, anemia, bloody stool, difficult swallowing

Design outcomes

Primary

MeasureTime frame
Severity assessment of dyspepsia. Timepoint: 4 times: baseline, 2,4 and 8 weeks. Method of measurement: The gastrointestinal severity symptom scale.;Quality of life. Timepoint: 3 times: baseline, 4, 8 weeks. Method of measurement: NDI10 quality of life scale.;Frequency assessment of dyspepsia. Timepoint: 4 times: baseline, 2,4 and 8 weeks. Method of measurement: Rome IV questionnaire.

Secondary

MeasureTime frame
Side effects. Timepoint: During 8 weeks study. Method of measurement: Side effects questionnnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Azimi

Kerman University of Medical Sciences

Dr.azimm@gmail.com+98 34 3211 0123

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026